celastrol has been researched along with Disease Exacerbation in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Chen, Y; Cheng, J; Chu, F; Ding, X; Du, S; Durojaye, OA; Gao, X; Li, Y; Liu, X; Shi, X; Song, X; Su, Z; Wang, D; Wang, F; Wang, J; Wang, T; Zeng, W | 1 |
Chen, F; Hou, L; Huang, L; Liu, Q; Shen, L; Wang, D; Zhang, X | 1 |
Chang, MY; Chen, KH; Chen, TD; Chen, YC; Hsieh, CY; Hsu, HH; Hung, CC; Lin, CY; Tian, YC; Yang, CW; Yang, HY | 1 |
Chen, X; Hu, C; Li, Z; Pang, B; Yi, H; Zhen, Y | 1 |
Astry, B; Moudgil, KD; Nanjundaiah, SM; Tong, L; Venkatesha, SH; Yu, H | 1 |
Cai, F; Liu, L; Liu, X; Yang, A; Zhang, Y | 1 |
Burstein, E; Dai, Y; Desano, J; Lawrence, TS; Meng, X; Meng, Y; Tang, W; Xu, L | 1 |
7 other study(ies) available for celastrol and Disease Exacerbation
Article | Year |
---|---|
Celastrol inhibits ezrin-mediated migration of hepatocellular carcinoma cells.
Topics: Biotin; Carcinoma, Hepatocellular; Catalytic Domain; Cell Movement; Cytoskeletal Proteins; Disease Progression; HEK293 Cells; Hep G2 Cells; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Molecular Docking Simulation; Neoplasm Invasiveness; Neoplasm Metastasis; Pentacyclic Triterpenes; Phosphorylation; rho-Associated Kinases; Triterpenes; Wound Healing | 2020 |
Nanocarrier-Mediated Chemo-Immunotherapy Arrested Cancer Progression and Induced Tumor Dormancy in Desmoplastic Melanoma.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Disease Progression; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Immunosenescence; Immunotherapy; Melanoma; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitoxantrone; Nanoparticles; NIH 3T3 Cells; Pentacyclic Triterpenes; Skin Neoplasms; Triterpenes; Tumor Microenvironment | 2018 |
Effect of celastrol on the progression of polycystic kidney disease in a Pkd1-deficient mouse model.
Topics: Animals; Cell Proliferation; Cysts; Disease Progression; Female; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pentacyclic Triterpenes; Polycystic Kidney, Autosomal Dominant; Triterpenes; TRPP Cation Channels | 2018 |
Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p.
Topics: Animals; Antineoplastic Agents; Argonaute Proteins; Cell Line, Tumor; Disease Progression; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice; MicroRNAs; Pentacyclic Triterpenes; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Triterpenes | 2019 |
Pristimerin, a naturally occurring triterpenoid, protects against autoimmune arthritis by modulating the cellular and soluble immune mediators of inflammation and tissue damage.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Autoimmune Diseases; Bone Remodeling; Cytokines; Disease Models, Animal; Disease Progression; Inflammation Mediators; Lymphocyte Count; Male; Matrix Metalloproteinase 9; Nuclear Receptor Subfamily 1, Group F, Member 3; Pentacyclic Triterpenes; Rats; STAT3 Transcription Factor; Synovial Membrane; T-Lymphocyte Subsets; Triterpenes | 2014 |
Celastrol, an NF-κB inhibitor, ameliorates hypercalciuria and articular cartilage lesions in a mouse model of secondary osteoporosis.
Topics: Adipose Tissue; Animals; Body Weight; Cartilage, Articular; Disease Models, Animal; Disease Progression; Hypercalciuria; Leptin; Lipid Metabolism; Male; Mice, Inbred C57BL; Molecular Targeted Therapy; NF-kappa B; Osteoporosis; Parathyroid Hormone; Pentacyclic Triterpenes; Triterpenes | 2016 |
Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB.
Topics: Androgens; Animals; Apoptosis; Cell Line, Tumor; Disease Progression; Enzyme Inhibitors; Female; Humans; Inhibitory Concentration 50; Male; Mice; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; NF-kappa B; Pentacyclic Triterpenes; Prostatic Neoplasms; Protease Inhibitors; Proteasome Inhibitors; Proto-Oncogene Proteins c-bcl-2; Triterpenes | 2010 |